SUN Pharmaceutical Industries Limited — Enalapril Exporter Profile
Indian Pharmaceutical Exporter · #14 for Enalapril · $1.0M export value · DGFT Verified
SUN Pharmaceutical Industries Limited is the #14 Indian exporter of Enalapril with $1.0M in export value and 71 verified shipments. SUN Pharmaceutical Industries Limited holds a 0.6% market share in Enalapril exports across 3 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.
SUN Pharmaceutical Industries Limited — Enalapril Export Profile: Buyers & Destinations
Where Does SUN Pharmaceutical Industries Limited Export Enalapril?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SOUTH AFRICA | $984.9K | 56 | 90.3% |
| CANADA | $90.7K | 17 | 8.3% |
| JAMAICA | $15.2K | 2 | 1.4% |
SUN Pharmaceutical Industries Limited exports Enalapril to 3 countries. The largest destination is SOUTH AFRICA accounting for 90.3% of SUN Pharmaceutical Industries Limited's Enalapril shipments, followed by CANADA (8.3%) and JAMAICA (1.4%). These destinations reflect SUN Pharmaceutical Industries Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Enalapril from SUN Pharmaceutical Industries Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| RANBAXY PHARMACEUTICALS PTY LIMITED | SOUTH AFRICA | $305.7K | 11 |
| RANBAXY PHARMACEUTICALS PTY LTD., | SOUTH AFRICA | $261.6K | 24 |
| RANBAXY PHARMACEUTICALS PTY LTD | SOUTH AFRICA | $211.5K | 9 |
| M/S. RANBAXY PHARMACETICALS PTY LTD | SOUTH AFRICA | $153.8K | 8 |
| SUN PHARMA CANADA INC | CANADA | $45.6K | 9 |
| M/S. RANBAXY PHARMACEUTICALS PTY LT | SOUTH AFRICA | $30.9K | 1 |
| SUN PHARMA CANADA INC. | CANADA | $21.5K | 4 |
| RANBAXY SOUTH AFRICA PTY LTD | SOUTH AFRICA | $15.1K | 2 |
| MS SUN PHARMA CANADA INC | CANADA | $9.8K | 1 |
| M/S. SUN PHARMA CANADA INC | CANADA | $9.3K | 2 |
SUN Pharmaceutical Industries Limited supplies Enalapril to 14 buyers globally. The largest buyer is RANBAXY PHARMACEUTICALS PTY LIMITED (SOUTH AFRICA), followed by RANBAXY PHARMACEUTICALS PTY LTD., (SOUTH AFRICA) and RANBAXY PHARMACEUTICALS PTY LTD (SOUTH AFRICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Enalapril Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?
India exported $32.4M worth of Enalapril through 3,403 shipments from 261 suppliers to 115 countries, serving 583 buyers globally. SUN Pharmaceutical Industries Limited contributes $1.0M to this total, accounting for 0.6% of India's Enalapril exports. SUN Pharmaceutical Industries Limited ships Enalapril to 3 countries through 14 buyers.
What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Enalapril Exports?
SUN Pharmaceutical Industries Limited's average Enalapril shipment value is $14.3K per consignment, based on 71 shipments totaling $1.0M. The largest destination is SOUTH AFRICA (90.3% of SUN Pharmaceutical Industries Limited's Enalapril exports).
How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Enalapril Exporters?
SUN Pharmaceutical Industries Limited ranks #14 among 261 Indian Enalapril exporters with a 0.6% market share. The top 3 exporters are IPCA LABORATORIES LIMITED ($6.2M), J B CHEMICALS AND PHARMACEUTICALS LIMITED ($4.8M), MYLAN LABORATORIES LIMITED ($4.5M). SUN Pharmaceutical Industries Limited processed 71 shipments to 3 destination countries.
What Enalapril Formulations Does SUN Pharmaceutical Industries Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ALAPREN TAB 10 MG(ENALAPRIL MALEATE TABL | $153.4K | 7 |
| ALAPREN TAB 10 MG (ENALAPRIL MALEATE TABLETS) EACH FILM COATED TABLET CONTAINS:ENALAPRIL MALEATE 10MG PACK : 4X7S | $97.1K | 3 |
| ALAPREN 5MG TABS EACH TAB CONTAINS ENALAPRIL MALEATE 5MG PACK : 4X7SPCS | $95.2K | 10 |
| ALAPREN TABS 10MG EACH TAB CONTAINS ENALAPRIL MALEATE 10MG PACK : 4x7s | $69.0K | 2 |
| ALAPREN 5MG TABS EACH TAB CONTAINS ENALAPRIL MALEATE 5MG PACK : 4x7s | $50.7K | 2 |
| ALAPREN 5MG TABS EACH TAB CONTAINS ENALAPRIL MALEATE 5MG PACK : SP 4x7s | $49.4K | 2 |
| ALAPREN 5MG TABS EACH TAB CONTAINS ENALAPRIL MALEATE 5MG PACK : SP 4x7s | $45.4K | 3 |
| ALAPREN 10MG TABS EACH TAB CONTAINS ENALAPRIL MALEATE 10MG PACK SP 7s Strip | $45.2K | 1 |
| ALAPREN 5MG TABS EACH TAB CONTAINS ENALAPRIL MALEATE 5MG : PACK : SP 4x7s | $39.8K | 4 |
| ALAPREN 5MG TABS EACH TAB CONTAINS ENALAPRIL MALEATE 5MG PACK SP 4x7s | $38.3K | 2 |
SUN Pharmaceutical Industries Limited exports 41 distinct Enalapril formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ALAPREN TAB 10 MG(ENALAPRIL MALEATE TABL with 7 shipments worth $153.4K.
Regulatory Requirements: Exporting Enalapril to Key Markets
What SUN Pharmaceutical Industries Limited must comply with to export Enalapril to its top destination countries
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does SUN Pharmaceutical Industries Limited Compare to Nearest Enalapril Exporters?
Exporters ranked immediately above and below #14 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | INTAS PHARMACEUTICALS LIMITED | $1.1M | 442 | 12 | $2.5K |
| 13 | MEDOPHARM | $1.0M | 84 | 12 | $12.4K |
| 14 | SUN PHARMACEUTICAL INDUSTRIES LIMITED ★ | $1.0M | 71 | 3 | $14.3K |
| 12 | BIOMATRIX HEALTHCARE PRIVATE LIMITED | $850.0K | 17 | 2 | $50.0K |
| 15 | ANNORA PHARMA PRIVATE LIMITED | $450.0K | 9 | 1 | $50.0K |
SUN Pharmaceutical Industries Limited ranks #14 among 261 Indian Enalapril exporters. Average shipment value of $14.3K compared to the market average of $124.2K. The closest competitors by value are INTAS PHARMACEUTICALS LIMITED and MEDOPHARM.
Which Indian Ports Ship Enalapril Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 474 | 13.9% |
| DELHI AIR CARGO ACC (INDEL4) | 340 | 10.0% |
| SAHAR AIR | 254 | 7.5% |
| JNPT/ NHAVA SHEVA SEA | 229 | 6.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 222 | 6.5% |
| JNPT | 213 | 6.3% |
| DELHI AIR | 210 | 6.2% |
| MUNDRA SEA (INMUN1) | 124 | 3.6% |
Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Enalapril Exports
Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)
In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)
The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)
SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)
Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.
About SUN Pharmaceutical Industries Limited
SUN Pharmaceutical Industries Limited exports 118 products worth $979.8M. Beyond Enalapril, top products include Strip, Esomeprazole, Magnesium, Calcium, Omeprazole. View the complete SUN Pharmaceutical Industries Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Enalapril — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Enalapril shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 75 individual customs records matching SUN Pharmaceutical Industries Limited exporting Enalapril, covering 41 formulations to 3 countries via 14 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 115+ countries, 583+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Enalapril Export Data from SUN Pharmaceutical Industries Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for SUN Pharmaceutical Industries Limited's Enalapril exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SUN Pharmaceutical Industries Limited
Full Company Profile →
118 products · $979.8M total trade · 25 categories
Enalapril Stats
Company Overview
Top Products by SUN Pharmaceutical Industries Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for SUN Pharmaceutical Industries Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Enalapril. For current shipment-level data, contact TransData Nexus.